García FA, García RJF, Gálvez GAM, Jimenez LG

Language: Spanish
References: 17
Page: 183-192
PDF size: 338.74 Kb.

ABSTRACT

Objective: To determine the methodical quality of complete economic evaluations published in Cuban medical journals from 1999 to 2014.
Methods: Observational, descriptive and cross-sectional study of articles classified by their authors as complete economic evaluations and published from 1999 to 2014 in 47 Cuban medical journals authorized by the Ministry of Science, Technology and Environment. The applied evaluation guide included year of publication, journal, objective, problem, options, time frame, prospects, cost, health effects and estimation of the cost/effectiveness ratio.
Results: Twenty one papers were found, but in the last three years no paper has been published. These papers were mainly published in eight journals, being the first Revista Cubana de Farmacia, followed by Revista Cubana de Salud Publica and MEDISAN. None of the aspects was correctly addressed in over 80 % of revised papers. The worst results were found in statement of perspective present in less than 20 % of papers in addition to sensitivity analysis in less than 30 % of them. Almost 50 of papers adequately dealt with the submission of research problems, objectives, time frame, costs and the incremental cost/effectiveness ratio.
Conclusions: Published economic evaluations are still scanty and most of them exhibit methodological faults. There is insufficient development in this area nationwide, which points to the importance of insisting once again on the dissemination of the basic methodological aspects of these evaluations aimed at researchers who act as reviewers and as editors of scientific journals.

REFERENCES

1. Taylor RS, Drummond MF, Salkeld G, Sullivan SD. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. BMJ. 2004;329(7472):972-5.

2. Brousselle A, Lessard C. Economic evaluation to inform health care decisionmaking: promise, pitfalls and a proposal for an alternative path. Social Science Med. 2011;72(6):832-9.

3. Lessarda CH, Contandriopoulosa AP, Beaulieub MD. The role (or not) of economic evaluation at the micro level: Can Bourdieu’s theory provide a way forward for clinical decision-making? Social Science Med. 2010;70(12):1948–56.

4. Rodríguez LP, Silva RR, Wacher NR. Estudios económicos y análisis de decisiones en la autogestión de recursos. Rev Med Inst Mex Seguro Soc. 2007;45(3):297-304.

5. Gálvez González AM, Álvarez Muñiz M, Sarduy Domínguez Y, Morales Laberón M. Diagnóstico de la evaluación económica en salud en Cuba. Rev Cubana Salud Pública. 2004 [citado 19 Dic 2014];30(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 34662004000100003&lng=es

6. Gálvez González AM. Guía metodológica para la evaluación económica en salud: Cuba, 2003. Rev Cubana Salud Pública. 2004 [citado 19 Dic 2014];30(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 34662004000100005&lng=es

7. García Fariñas A, Gálvez González AM, García Rodríguez JF. Aspectos metodológicos críticos en las evaluaciones económicas de salud en el contexto cubano. Rev Cubana Salud Pública. 2010 [citado 19 Dic 2014];36(3):233-5. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 34662010000300007&lng=es

8. Gálvez González AM, Garcia Fariñas A, Portuondo Sánchez C, Lara Bastanzuri C, Collazo Herrera M. Evaluación económica en salud y toma de decisiones en el contexto sanitario cubano. Rev Cubana Salud Pública. 2012 [citado 19 Dic 2014];38(2):253-62. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 34662012000200008&lng=es

9. Ministerio de Salud Pública. Transformaciones necesarias en el sistema de salud pública. La Habana: Ministerio; 2010. Disponible en: http://files.sld.cu/editorhome/files/2010/11/transformaciones-necesarias-saludpublica. pdf

10. Gálvez González AM, García Fariñas A, Portuondo Sánchez C. Producción científica en la maestría de economía de la salud desde la perspectiva de las tesis. Educ Med Super. 2011 [citado 19 Dic 2014];25(4):389-97. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 21412011000400001&lng=es

11. Leung HW, Chan AL, Leung MS, Lu CL. Systematic review and quality assessment of cost-effectiveness analysis of pharmaceutical therapies for advanced colorectal cancer. Ann Pharmacotherapy. 2013;47(4):506-518.

12. Gálvez González AM. Economía de la salud en el contexto de la salud pública cubana. Rev Cubana Salud Pública. 2003 [citado 19 Dic 2014];29(4). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 34662003000400011&lng=es

13. Schwappach DLB, Boluarte TA. HEE-GER: a systematic review of German economic evaluations of health care published 1990–2004. BMC Health Services Res. 2007;7(1):7.

14. García-Altés A. Twenty years of health care economic analysis in Spain: are we doing well? Health Econ. 2001;10(8):715-29.

15. Iglesias CP, Drummond MF, Rovira J. Health-care decision-making processes in Latin America: problems and prospects for the use of economic evaluation. Internat J Technol Assess Health Care. 2005;21(01):1-14.

16. Neumann PJ, Greenberg D, Olchanski NV, Stone PW, Rosen AB. Growth and quality of the cost-utility literature, 1976-2001. Value Health. 2005;8(1):3-9.

17. Schumock GT, Meek PD, Ploetz PA. Economic evaluations of clinical pharmacy services. Pharmacotherapy. 1999;19(5):555.